HIGHLIGHTS
- who: Seyed Ahmad Hosseini from the Universitu00e9 Chouaib Doukkali, Morocco Ahvaz Jundishapur University of, Iran have published the research: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial, in the Journal: (JOURNAL)
- what: Considering that inflammation is an integral part of the MS pathogenesis and reducing the level of inflammation can be effective in the treatment of this disease, this study aimed to investigate the effect of probiotic supplementation on systemic inflammation in patients with MS. This study was a 12-week randomized, double-blind clinical trial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.